European Commission approves contract with BioNTech-Pfizer alliance

Today, the European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further 100 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Development Research and Development Source Type: news